Twist Bioscience Corp diskutieren
Twist Bioscience Corp
WKN: A2N7L2 / Symbol: TWST / Name: Twist Bioscience / Aktie / Pharmazeutika / Small Cap /
51,60 €
2,73 %
Twist Bioscience Co. (NASDAQ: TWST) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $45.00 price target on the stock, up previously from $25.00.
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Barclays PLC from $30.00 to $45.00. They now have an "overweight" rating on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its price target lowered by analysts at Barclays PLC from $45.00 to $40.00. They now have an "overweight" rating on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Robert W. Baird from $39.00 to $40.00. They now have an "outperform" rating on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Barclays PLC from $40.00 to $45.00. They now have an "overweight" rating on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Evercore ISI from $46.00 to $50.00. They now have an "outperform" rating on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) is now covered by analysts at Guggenheim. They set a "buy" rating and a $53.00 price target on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at TD Cowen from $55.00 to $65.00. They now have a "buy" rating on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Barclays PLC from $45.00 to $60.00. They now have an "overweight" rating on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $45.00 to $55.00. They now have a "buy" rating on the stock.
Ratings data for TWST provided by MarketBeat
Neueste Beiträge
DA_Davidson in Medifast Inc. diskutieren